Masimo Corp. and SunTech Medical, a Halma company, jointly announced the integration of Masimo Signal Extraction Technology (SET) pulse oximetry technology into SunTech’s CT40, a next generation spot-check vital signs device.
The SET pulse oximetry measures oxygen saturation (SpO 2 ), pulse rate, and perfusion index. It has been shown to reduce false alarms and accurately monitor for true alarms and is estimated to be used on more than 100 million patients in hospitals and other healthcare settings around the world.
The SunTech CT40 is an affordable option for clinical-grade spot-check measurements of blood pressure, temperature and pulse oximetry in hospitals and clinics. Ambulatory care, long-term care and low-acuity hospital departments can implement the vital signs device, which offers both advanced features and digital connectivity.
The modular design allows clinicians to make adaptations to the device while in the field, adding thermometry, SpO 2 and Wi-Fi as needed.
Other advanced features include the ability to transmit measurement data directly from the device, in accordance with HL7 messaging protocols, as well as BP Averaging Mode — an increasingly important component of accurate blood pressure measurement, as evidenced by the recently published SPRINT Study from the National Institutes of Health (NIH), which specified that a mean of three office BP measurements would be used to establish target BPs for Standard Group participants.
The SunTech CT 40 with Masimo SET technology has a CE Mark. It is not FDA cleared and is not available for sale in the United States.
